Price T Rowe Associates Inc. MD Has $55.23 Million Stock Holdings in Teradyne, Inc. (NASDAQ:TER)

Price T Rowe Associates Inc. MD decreased its holdings in shares of Teradyne, Inc. (NASDAQ:TER) by 16.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 438,631 shares of the company’s stock after selling 84,772 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 0.27% of Teradyne worth $55,234,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Van ECK Associates Corp increased its position in Teradyne by 59.9% during the 4th quarter. Van ECK Associates Corp now owns 4,928,143 shares of the company’s stock worth $620,552,000 after buying an additional 1,846,079 shares during the period. Proficio Capital Partners LLC bought a new position in Teradyne during the 4th quarter worth $12,118,000. Franklin Resources Inc. increased its position in Teradyne by 30.5% during the 3rd quarter. Franklin Resources Inc. now owns 88,879 shares of the company’s stock worth $11,878,000 after buying an additional 20,762 shares during the period. Empowered Funds LLC increased its position in Teradyne by 16.2% during the 4th quarter. Empowered Funds LLC now owns 30,269 shares of the company’s stock worth $3,811,000 after buying an additional 4,212 shares during the period. Finally, Boston Trust Walden Corp increased its position in Teradyne by 3.3% during the 4th quarter. Boston Trust Walden Corp now owns 408,177 shares of the company’s stock worth $51,398,000 after buying an additional 13,020 shares during the period. Institutional investors and hedge funds own 99.77% of the company’s stock.

Insider Transactions at Teradyne

In other Teradyne news, CFO Sanjay Mehta sold 1,384 shares of the firm’s stock in a transaction on Tuesday, February 4th. The shares were sold at an average price of $111.49, for a total value of $154,302.16. Following the completion of the sale, the chief financial officer now directly owns 36,576 shares in the company, valued at approximately $4,077,858.24. This trade represents a 3.65 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Ryan Driscoll sold 437 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $102.00, for a total transaction of $44,574.00. Following the completion of the sale, the vice president now owns 4,312 shares of the company’s stock, valued at $439,824. The trade was a 9.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 3,096 shares of company stock worth $335,199 over the last three months. 0.16% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

TER has been the topic of several recent research reports. UBS Group set a $130.00 price objective on Teradyne and gave the stock a “buy” rating in a research report on Wednesday, March 12th. Cantor Fitzgerald decreased their price target on Teradyne from $150.00 to $110.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 12th. Stifel Nicolaus decreased their price target on Teradyne from $125.00 to $110.00 and set a “hold” rating on the stock in a research report on Wednesday, March 12th. Morgan Stanley decreased their price target on Teradyne from $81.00 to $69.00 and set an “underweight” rating on the stock in a research report on Wednesday, April 16th. Finally, Northland Securities decreased their price target on Teradyne from $154.00 to $140.00 and set an “outperform” rating on the stock in a research report on Friday, January 31st. Two research analysts have rated the stock with a sell rating, four have given a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Teradyne has an average rating of “Moderate Buy” and an average target price of $118.94.

Teradyne Stock Performance

Shares of NASDAQ TER opened at $76.83 on Tuesday. Teradyne, Inc. has a 52-week low of $65.77 and a 52-week high of $163.21. The firm has a 50 day moving average price of $87.49 and a two-hundred day moving average price of $108.38. The stock has a market cap of $12.36 billion, a P/E ratio of 23.07, a price-to-earnings-growth ratio of 2.83 and a beta of 1.65.

Teradyne (NASDAQ:TER) last announced its quarterly earnings results on Monday, April 28th. The company reported $0.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.61 by $0.14. Teradyne had a net margin of 19.23% and a return on equity of 19.08%. The firm had revenue of $685.70 million during the quarter, compared to analysts’ expectations of $680.54 million. Analysts predict that Teradyne, Inc. will post 3.88 earnings per share for the current fiscal year.

Teradyne declared that its board has authorized a share repurchase plan on Monday, April 28th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 8.1% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

Teradyne Company Profile

Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.